Literature DB >> 3013204

Studies of the digestion of bradykinin, Lys-bradykinin, and des-Arg9-bradykinin by angiotensin converting enzyme.

I A Sheikh, A P Kaplan.   

Abstract

We have studied the degradation of bradykinin, lysyl bradykinin and des-Arg9-bradykinin by the angiotensin converting enzyme. Bradykinin was cleaved at two sites to produce the pentapeptide Arg-Pro-Pro-Gly-Phe plus dipeptides Ser-Pro and Phe-Arg. Lysyl bradykinin was cleaved similarly to release the same dipeptides plus the hexapeptide Lys-Arg-Pro-Pro-Gly-Phe. The tripeptidase activity of ACE was observed when des-Arg9-bradykinin was digested. A single cleavage yielded the above pentapeptide plus Ser-Pro-Phe. Although des-Arg9-bradykinin was the most rapidly digested, when mixtures of des-Arg9-bradykinin and bradykinin or lysyl bradykinin were tested, virtually all of the bradykinin and most of the lysyl bradykinin was digested prior to the onset of digestion of des-Arg9-bradykinin. This was shown to be due to inhibition of des-Arg9-bradykinin cleavage by kinins and kinin-degradation products. The order in terms of potency was bradykinin greater than lysyl bradykinin greater than Ser-Pro much greater than Phe-Arg greater than Arg-Pro-Pro-Gly-Phe. The concentration of chloride ion was an important parameter which affected the rate of digestion of each substrate examined. des-Arg9-bradykinin was not digested by ACE in the absence of sodium chloride and the rate of digestion increased as the chloride concentration was increased to 100-150 mM. On the other hand, increasing NaCl concentration was inhibitory for bradykinin digestion. The rate of Lys-bradykinin digestion was increased from 0 to 1 mM NaCl and decreased thereafter up to physiologic concentration. A half-maximal rate was seen at 100-150 mM NaCl compared to no salt. Of the divalent cations examined, cupric ion inhibited further digestion of des-Arg9-bradykinin at physiologic concentrations. Our data indicate that the rate of degradation of kinins and the nature of the stable final cleavage products in plasma or serum (studied in vitro) are dependent upon the effects of chloride ion, metal ions, and the kinetic effects of multiple metabolites produced by at least two kininases.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3013204     DOI: 10.1016/0006-2952(86)90726-4

Source DB:  PubMed          Journal:  Biochem Pharmacol        ISSN: 0006-2952            Impact factor:   5.858


  13 in total

Review 1.  Bradykinin formation. Plasma and tissue pathways and cellular interactions.

Authors:  A P Kaplan; K Joseph; Y Shibayama; Y Nakazawa; B Ghebrehiwet; S Reddigari; M Silverberg
Journal:  Clin Rev Allergy Immunol       Date:  1998       Impact factor: 8.667

2.  Metabolism of bradykinin and angiotensin I by human basilar artery and rabbit aorta.

Authors:  E T Whalley
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1987-05       Impact factor: 3.000

Review 3.  Localization and regulation of the renal kallikrein kinin system: possible relations to renal transport functions.

Authors:  W G Guder; J Hallbach
Journal:  Klin Wochenschr       Date:  1988-09-15

4.  Degradation pathway of kinins in tumor ascites and inhibition by kininase inhibitors: analysis by HPLC.

Authors:  Y Matsumura; H Maeda; H Kato
Journal:  Agents Actions       Date:  1990-03

5.  Identification of receptor ligands and receptor subtypes using antagonists in a capillary electrophoresis single-cell biosensor separation system.

Authors:  H A Fishman; O Orwar; R H Scheller; R N Zare
Journal:  Proc Natl Acad Sci U S A       Date:  1995-08-15       Impact factor: 11.205

6.  Effect of enalapril on allergen-induced cutaneous hypersensitivity reaction.

Authors:  J R Snyman; D K Sommers
Journal:  Br J Clin Pharmacol       Date:  1991-12       Impact factor: 4.335

7.  Receptors mediating the increase in vascular permeability to kinins: comparative studies in rat, guinea-pig and rabbit.

Authors:  E T Whalley
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1987-07       Impact factor: 3.000

8.  The contribution of gC1qR/p33 in infection and inflammation.

Authors:  Ellinor I B Peerschke; Berhane Ghebrehiwet
Journal:  Immunobiology       Date:  2007-01-03       Impact factor: 3.144

9.  Effects of the bradykinin antagonist B4310 on smooth muscles and blood pressure in the rat, and its enzymatic degradation.

Authors:  T Griesbacher; F Lembeck; A Saria
Journal:  Br J Pharmacol       Date:  1989-03       Impact factor: 8.739

10.  Angioedema.

Authors:  Allen P Kaplan
Journal:  World Allergy Organ J       Date:  2008-06       Impact factor: 4.084

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.